{"id":941044,"date":"2026-03-02T10:58:18","date_gmt":"2026-03-02T15:58:18","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/tectonic-therapeutic-to-participate-in-march-investor-conferences-2\/"},"modified":"2026-03-02T10:58:18","modified_gmt":"2026-03-02T15:58:18","slug":"tectonic-therapeutic-to-participate-in-march-investor-conferences-2","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/tectonic-therapeutic-to-participate-in-march-investor-conferences-2\/","title":{"rendered":"Tectonic Therapeutic to Participate in March Investor Conferences"},"content":{"rendered":"<div class=\"mw_release\">\n<p>WATERTOWN, Mass., March  02, 2026  (GLOBE NEWSWIRE) &#8212; <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=USLknVc-Rj1NyzzPkYCS4saYNxB3qWTNWram5XZzVc8lv6ZK4bGP_Hr2QrCTl86fRgQtcL59xK-hp9t_ZuV-mBDa7MT6LIYvFt10qoqDCoY=\" rel=\"nofollow\" target=\"_blank\">Tectonic Therapeutic<\/a>, Inc. (NASDAQ: TECX) (\u201cTectonic\u201d), a clinical stage biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of G-protein coupled receptors (GPCRs), today announced that company management will participate in two upcoming investor conferences taking place in March 2026.<\/p>\n<table style=\"border-collapse: collapse;width:100%;border-collapse:collapse\">\n<tr>\n<td colspan=\"2\" style=\"width:100.023%\">\n            <strong>TD Cowen 46th Annual Health Care Conference<\/strong>\n          <\/td>\n<\/tr>\n<tr>\n<td style=\"max-width:10%;width:9.98152%;min-width:10%\">\u00a0<\/td>\n<td style=\"max-width:90%;width:90.0416%;min-width:90%\">\u00a0<\/td>\n<\/tr>\n<tr>\n<td style=\"width:9.98152%\">Date:<\/td>\n<td style=\"width:90.0416%\">March 4, 2026<\/td>\n<\/tr>\n<tr>\n<td style=\"width:9.98152%\">Time:<\/td>\n<td style=\"width:90.0416%\">11:10 AM EST<\/td>\n<\/tr>\n<tr>\n<td style=\"width:9.98152%\">Location:<\/td>\n<td style=\"width:90.0416%\">Boston, MA<\/td>\n<\/tr>\n<tr>\n<td style=\"width:9.98152%\">Format:<\/td>\n<td style=\"width:90.0416%\">Fireside Chat<\/td>\n<\/tr>\n<tr>\n<td style=\"width:9.98152%\">Presenters:<\/td>\n<td style=\"width:90.0416%\">Alise Reicin, MD, President and Chief Executive Officer<\/td>\n<\/tr>\n<tr>\n<td style=\"width:9.98152%\">Webcast:<\/td>\n<td style=\"width:90.0416%\">\n            <a href=\"https:\/\/event.summitcast.com\/view\/9z5g2VrV6e6rbCqQgDRoHA\/guest_book?session_id=34jWUcefXrux5HJjQPvQAz\" rel=\"nofollow\" target=\"_blank\">Link<\/a>\n          <\/td>\n<\/tr>\n<tr>\n<td style=\"width:9.98152%\">\u00a0<\/td>\n<td style=\"width:90.0416%\">\u00a0<\/td>\n<\/tr>\n<tr>\n<td colspan=\"2\" style=\"width:100.023%\">\n            <strong>Leerink Global Healthcare Conference<\/strong><br \/>\n            \n          <\/td>\n<\/tr>\n<tr>\n<td style=\"width:9.98152%\">\u00a0<\/td>\n<td style=\"width:90.0416%\">\u00a0<\/td>\n<\/tr>\n<tr>\n<td style=\"width:9.98152%\">\n            <strong>Date:<br \/><\/strong>\n          <\/td>\n<td style=\"width:90.0416%\">March 11, 2026<\/td>\n<\/tr>\n<tr>\n<td style=\"width:9.98152%\">\n            <strong>Time:<br \/><\/strong>\n          <\/td>\n<td style=\"width:90.0416%\">1:40 PM EST<\/td>\n<\/tr>\n<tr>\n<td style=\"width:9.98152%\">\n            <strong>Location:<br \/><\/strong>\n          <\/td>\n<td style=\"width:90.0416%\">Miami, FL<\/td>\n<\/tr>\n<tr>\n<td style=\"width:9.98152%\">\n            <strong>Format:<br \/><\/strong>\n          <\/td>\n<td style=\"width:90.0416%\">Fireside Chat<\/td>\n<\/tr>\n<tr>\n<td style=\"width:9.98152%\">\n            <strong>Presenters:<br \/><\/strong>\n          <\/td>\n<td style=\"width:90.0416%\">Alise Reicin, MD, President and Chief Executive Officer<\/td>\n<\/tr>\n<tr>\n<td style=\"width:9.98152%\">\n            <strong>Webcast:<br \/><\/strong>\n          <\/td>\n<td style=\"width:90.0416%\">\n            <a href=\"https:\/\/event.summitcast.com\/view\/mT9poctHDNthc6b89WqVjf\/guest_book?session_id=EkeAuaF8ac4cFf4ud8GUkR\" rel=\"nofollow\" target=\"_blank\">Link<\/a>\n          <\/td>\n<\/tr>\n<\/table>\n<p>\n        <br \/>The live fireside chats can also be accessed under \u201c<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=1484FKK5vJR_rY1ilTHZScIP4l53tFjqXYKUPJt20No4hSoLeJyljW0IPkO-07N5XcKzAuzH3dDxliBvulYGAq_uVWrwak--yZn8L5AuwuY3JeUBaUJAuTemVAW-oAZoYuB6j0k3UafoRZR6SdZaDgxIA8s00YOQzvT0nY2xrMY=\" rel=\"nofollow\" target=\"_blank\">Events &amp; Presentations<\/a>\u201d on the Investors section of the Tectonic website at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=lA_jZ51InlY-Wl7zpFHfcq8dJ3tbY1TLf-jQkeb3L-G8uvVgit8D-vaSgom3vuOhIz2yzoWucA_dAGTpbofg79xiqIWdOWmLB515S8nDc-E=\" rel=\"nofollow\" target=\"_blank\">www.tectonictx.com<\/a>. A replay of the webcasts will be available on the Company\u2019s website for approximately 90 days.<\/p>\n<p>The Tectonic management team will host one-on-one meetings during the two conferences.\u00a0Interested investors should contact their\u00a0TD Cowen and Leerink representatives to schedule meetings.<\/p>\n<p>\n        <strong>About Tectonic<\/strong><br \/>\n        <br \/>\n        <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=USLknVc-Rj1NyzzPkYCS4vLZBIf-VDKrDAk8S_mqpSupK4VbNRJIaymgRW7sld1KBFEShP9lreId7giPRoJstr_unKB6PkJBy1H_PCRD7Ps=\" rel=\"nofollow\" target=\"_blank\">Tectonic Therapeutic\u00a0<\/a>is a clinical-stage biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of GPCRs. Leveraging its proprietary technology platform called GEODe\u2122 (GPCRs Engineered for Optimal Discovery), Tectonic is focused on developing biologic medicines that overcome the existing challenges of GPCR-targeted drug discovery and harness the human body to modify the course of disease. Tectonic focuses on areas of significant unmet medical need, often where therapeutic options are poor or nonexistent, as these are areas where new medicines have the potential to improve patient quality of life. Tectonic is headquartered in\u00a0Watertown, Massachusetts. For more information, please visit\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=lA_jZ51InlY-Wl7zpFHfclz4lVPBzKx6gYzGoPVpumiqSjfd9M8pAX3lnKIT5SK0vk9w7sP7xrBlpulyugZkWgVQxXhqGJ7LgjXyQTvWDWc=\" rel=\"nofollow\" target=\"_blank\">www.tectonictx.com<\/a>\u00a0and follow us on\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=o4GhgKPt4ebz7X4mRDJPIhsVKUOKMn-a5q1ZgZpJcVG8V1j9nm9pS9F14-ZMKQ4XZcTy441BWbPnRl-JlopOCtGaf7ZTQ8KVibvwhy-4is4=\" rel=\"nofollow\" target=\"_blank\">LinkedIn<\/a>.<\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY2MzIxNCM3NDYwMjExIzIxMDAxNTc=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/YTM2YmU0NWUtZWUzMS00YWUyLTlkOTctMGRmMTEwYTkxYTc5LTExMTE3MjgtMjAyNi0wMy0wMi1lbg==\/tiny\/Tectonic-Therapeutic.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\">\n<pre>Contacts:\r\n\r\nInvestors:\r\nDan Ferry\r\nLifeSci Advisors\r\n(617) 430-7576\r\ndaniel@lifesciadvisors.com\r\n\r\nMedia:\r\nKathryn Morris\r\nThe Yates Network\r\n(914) 204-6412\r\nkathryn@theyatesnetwork.com<\/pre>\n<\/p><\/div>\n","protected":false},"excerpt":{"rendered":"<p>WATERTOWN, Mass., March 02, 2026 (GLOBE NEWSWIRE) &#8212; Tectonic Therapeutic, Inc. (NASDAQ: TECX) (\u201cTectonic\u201d), a clinical stage biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of G-protein coupled receptors (GPCRs), today announced that company management will participate in two upcoming investor conferences taking place in March 2026. TD Cowen 46th Annual Health Care Conference \u00a0 \u00a0 Date: March 4, 2026 Time: 11:10 AM EST Location: Boston, MA Format: Fireside Chat Presenters: Alise Reicin, MD, President and Chief Executive Officer Webcast: Link \u00a0 \u00a0 Leerink Global Healthcare Conference \u00a0 \u00a0 Date: March 11, 2026 Time: 1:40 PM EST Location: Miami, FL Format: Fireside Chat Presenters: Alise Reicin, MD, President and Chief Executive &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/tectonic-therapeutic-to-participate-in-march-investor-conferences-2\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Tectonic Therapeutic to Participate in March Investor Conferences&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-941044","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Tectonic Therapeutic to Participate in March Investor Conferences - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/tectonic-therapeutic-to-participate-in-march-investor-conferences-2\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Tectonic Therapeutic to Participate in March Investor Conferences - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"WATERTOWN, Mass., March 02, 2026 (GLOBE NEWSWIRE) &#8212; Tectonic Therapeutic, Inc. (NASDAQ: TECX) (\u201cTectonic\u201d), a clinical stage biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of G-protein coupled receptors (GPCRs), today announced that company management will participate in two upcoming investor conferences taking place in March 2026. TD Cowen 46th Annual Health Care Conference \u00a0 \u00a0 Date: March 4, 2026 Time: 11:10 AM EST Location: Boston, MA Format: Fireside Chat Presenters: Alise Reicin, MD, President and Chief Executive Officer Webcast: Link \u00a0 \u00a0 Leerink Global Healthcare Conference \u00a0 \u00a0 Date: March 11, 2026 Time: 1:40 PM EST Location: Miami, FL Format: Fireside Chat Presenters: Alise Reicin, MD, President and Chief Executive &hellip; Continue reading &quot;Tectonic Therapeutic to Participate in March Investor Conferences&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/tectonic-therapeutic-to-participate-in-march-investor-conferences-2\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2026-03-02T15:58:18+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY2MzIxNCM3NDYwMjExIzIxMDAxNTc=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tectonic-therapeutic-to-participate-in-march-investor-conferences-2\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tectonic-therapeutic-to-participate-in-march-investor-conferences-2\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Tectonic Therapeutic to Participate in March Investor Conferences\",\"datePublished\":\"2026-03-02T15:58:18+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tectonic-therapeutic-to-participate-in-march-investor-conferences-2\\\/\"},\"wordCount\":298,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tectonic-therapeutic-to-participate-in-march-investor-conferences-2\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTY2MzIxNCM3NDYwMjExIzIxMDAxNTc=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tectonic-therapeutic-to-participate-in-march-investor-conferences-2\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tectonic-therapeutic-to-participate-in-march-investor-conferences-2\\\/\",\"name\":\"Tectonic Therapeutic to Participate in March Investor Conferences - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tectonic-therapeutic-to-participate-in-march-investor-conferences-2\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tectonic-therapeutic-to-participate-in-march-investor-conferences-2\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTY2MzIxNCM3NDYwMjExIzIxMDAxNTc=\",\"datePublished\":\"2026-03-02T15:58:18+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tectonic-therapeutic-to-participate-in-march-investor-conferences-2\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tectonic-therapeutic-to-participate-in-march-investor-conferences-2\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tectonic-therapeutic-to-participate-in-march-investor-conferences-2\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTY2MzIxNCM3NDYwMjExIzIxMDAxNTc=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTY2MzIxNCM3NDYwMjExIzIxMDAxNTc=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tectonic-therapeutic-to-participate-in-march-investor-conferences-2\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Tectonic Therapeutic to Participate in March Investor Conferences\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Tectonic Therapeutic to Participate in March Investor Conferences - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/tectonic-therapeutic-to-participate-in-march-investor-conferences-2\/","og_locale":"en_US","og_type":"article","og_title":"Tectonic Therapeutic to Participate in March Investor Conferences - Market Newsdesk","og_description":"WATERTOWN, Mass., March 02, 2026 (GLOBE NEWSWIRE) &#8212; Tectonic Therapeutic, Inc. (NASDAQ: TECX) (\u201cTectonic\u201d), a clinical stage biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of G-protein coupled receptors (GPCRs), today announced that company management will participate in two upcoming investor conferences taking place in March 2026. TD Cowen 46th Annual Health Care Conference \u00a0 \u00a0 Date: March 4, 2026 Time: 11:10 AM EST Location: Boston, MA Format: Fireside Chat Presenters: Alise Reicin, MD, President and Chief Executive Officer Webcast: Link \u00a0 \u00a0 Leerink Global Healthcare Conference \u00a0 \u00a0 Date: March 11, 2026 Time: 1:40 PM EST Location: Miami, FL Format: Fireside Chat Presenters: Alise Reicin, MD, President and Chief Executive &hellip; Continue reading \"Tectonic Therapeutic to Participate in March Investor Conferences\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/tectonic-therapeutic-to-participate-in-march-investor-conferences-2\/","og_site_name":"Market Newsdesk","article_published_time":"2026-03-02T15:58:18+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY2MzIxNCM3NDYwMjExIzIxMDAxNTc=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tectonic-therapeutic-to-participate-in-march-investor-conferences-2\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tectonic-therapeutic-to-participate-in-march-investor-conferences-2\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Tectonic Therapeutic to Participate in March Investor Conferences","datePublished":"2026-03-02T15:58:18+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tectonic-therapeutic-to-participate-in-march-investor-conferences-2\/"},"wordCount":298,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tectonic-therapeutic-to-participate-in-march-investor-conferences-2\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY2MzIxNCM3NDYwMjExIzIxMDAxNTc=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tectonic-therapeutic-to-participate-in-march-investor-conferences-2\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/tectonic-therapeutic-to-participate-in-march-investor-conferences-2\/","name":"Tectonic Therapeutic to Participate in March Investor Conferences - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tectonic-therapeutic-to-participate-in-march-investor-conferences-2\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tectonic-therapeutic-to-participate-in-march-investor-conferences-2\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY2MzIxNCM3NDYwMjExIzIxMDAxNTc=","datePublished":"2026-03-02T15:58:18+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tectonic-therapeutic-to-participate-in-march-investor-conferences-2\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/tectonic-therapeutic-to-participate-in-march-investor-conferences-2\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tectonic-therapeutic-to-participate-in-march-investor-conferences-2\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY2MzIxNCM3NDYwMjExIzIxMDAxNTc=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY2MzIxNCM3NDYwMjExIzIxMDAxNTc="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tectonic-therapeutic-to-participate-in-march-investor-conferences-2\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Tectonic Therapeutic to Participate in March Investor Conferences"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/941044","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=941044"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/941044\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=941044"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=941044"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=941044"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}